Cite
HARVARD Citation
Ronit, A. et al. (2018). Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study. Journal of infectious diseases. pp. 405-412. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ronit, A. et al. (2018). Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study. Journal of infectious diseases. pp. 405-412. [Online].